| Literature DB >> 33931859 |
David Soriano-Castell1, Zhibin Liang1, Pamela Maher1, Antonio Currais1.
Abstract
Oxytosis/ferroptosis is a form of non-apoptotic regulated cell death characterized by glutathione (GSH) depletion and dysregulated production of mitochondrial ROS that results in lethal lipid peroxidation. As the significance of oxytosis/ferroptosis to age-associated human diseases is now beginning to be appreciated, the development of innovative approaches to identify novel therapeutics that target the oxytosis/ferroptosis pathway could not be more timely. Due to their sessile nature, plants are exposed to a variety of stresses that trigger physiological changes similar to those found in oxytosis/ferroptosis. As such, they have evolved a rich array of chemical strategies to deal with those challenging conditions. This review details a drug discovery approach for identifying potent inhibitors of oxytosis/ferroptosis from plants for the treatment of Alzheimer's disease and related dementias, thereby highlighting the tremendous potential of plant-based research for developing new medicines while simultaneously being a catalyst for sustainability.Entities:
Keywords: dementia; drug discovery; lipid peroxidation; oxidative stress; phenotypic screening; plant secondary metabolites
Mesh:
Substances:
Year: 2021 PMID: 33931859 PMCID: PMC9291238 DOI: 10.1111/bph.15517
Source DB: PubMed Journal: Br J Pharmacol ISSN: 0007-1188 Impact factor: 9.473